{"id":791298,"date":"2024-11-29T13:08:50","date_gmt":"2024-11-29T18:08:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/"},"modified":"2024-11-29T13:08:50","modified_gmt":"2024-11-29T18:08:50","slug":"polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/","title":{"rendered":"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance"},"content":{"rendered":"
\n

PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (\u201cNasdaq\u201d) notifying the Company that it is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, listing Rule 5550(b)(1), due to its failure to maintain a minimum of $2,500,000 in stockholders’ equity. In the Company’s Form 6-K dated November 13, 2024, the Company reported stockholders’ equity of approximately $2,158,000 as of September 30, 2024.<\/p>\n

In accordance with Nasdaq rules, the Company has 45 calendar days, or until January 9, 2025, to submit a plan to regain compliance. If the plan is accepted, Nasdaq can grant an extension of up to 180 calendar days from the date of the letter to evidence compliance. The Notification Letter has no immediate effect on the Company\u2019s listing on the Nasdaq Capital Market, and during the grace period, as may be extended, the Company\u2019s ordinary shares will continue to trade on Nasdaq under the symbol \u201cPYPD\u201d.<\/p>\n

Outcome of the unblinded interim analysis in Company\u2019s ongoing SHIELD II Phase 3 trial evaluating\u00a0D-PLEX\u2081\u2080\u2080 for the prevention of abdominal colorectal surgical site infections is expected in December 2024. Under the terms of the Company\u2019s private placement financing that closed in\u00a0January 2024\u00a0(\u201cJanuary PIPE\u201d),\u00a0the Company\u00a0has the potential to secure an additional\u00a0$18.5 million\u00a0if the unblinded interim analysis\u00a0results in the stopping of the trial due to positive efficacy and all warrants are exercised. In addition, under the terms of the private placement financing that closed in\u00a0August 2024\u00a0(\u201cAugust PIPE\u201d),\u00a0the Company\u00a0has the potential to secure an additional\u00a0$6.1 million\u00a0if the unblinded interim analysis results in either the stopping of the trial due to positive efficacy, or continuation to planned patient recruitment (up to 630 subjects) and all warrants are exercised. The Company expects that it will be able to demonstrate compliance with the Nasdaq stockholders\u2019 equity requirement if warrants issued under the January PIPE and the August PIPE are exercised.<\/p>\n

\n About\u00a0PolyPid<\/strong>\n <\/p>\n

\n PolyPid Ltd.<\/a>\u00a0(Nasdaq:\u00a0PYPD<\/a>) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid\u2019s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid\u2019s lead product candidate\u00a0D-PLEX\u2081\u2080\u2080 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional Company information, please visit\u00a0http:\/\/www.polypid.com<\/a>\u00a0and follow us on\u00a0Twitter<\/a>\u00a0and\u00a0LinkedIn<\/a>.<\/p>\n

\n Forward-looking Statements <\/strong>\n <\/p>\n

This press release contains \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as \u201cexpects,\u201d \u201canticipates,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cbelieves,\u201d \u201cseeks,\u201d \u201cestimates\u201d and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses regaining compliance with Nasdaq\u2019s continued listing requirements, the timing and effect thereof, and Company\u2019s expectation that\u00a0if warrants issued in the January PIPE and August PIPE\u00a0are exercised, the Company will be able to demonstrate compliance with the Nasdaq stockholders\u2019 equity requirement. Forward-looking statements are not historical facts, and are based upon management\u2019s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management\u2019s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company\u2019s reports filed from time to time with the\u00a0Securities and Exchange Commission, including, but not limited to, the risks detailed in the Company\u2019s Annual Report on Form 20-F filed on\u00a0March 6, 2024. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements.<\/p>\n

References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.\u00a0PolyPid\u00a0is not responsible for the contents of third-party websites.<\/p>\n

\n Contacts: <\/strong>
\n
PolyPid Ltd.\u00a0
Ori Warshavsky
COO \u2013 US
908-858-5995
IR@Polypid.com<\/a><\/p>\n

\n Investors:<\/strong>
\n
Brian Ritchie
LifeSci Advisors
212-915-2578
BRitchie@lifesciadvisors.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (\u201cNasdaq\u201d) notifying the Company that it is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, listing Rule 5550(b)(1), due to its failure to maintain a minimum of $2,500,000 in stockholders’ equity. In the Company’s Form 6-K dated November 13, 2024, the Company reported stockholders’ equity of approximately $2,158,000 as of September 30, 2024. In accordance with Nasdaq rules, the Company has … <\/p>\n

Continue reading “PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-791298","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (\u201cNasdaq\u201d) notifying the Company that it is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, listing Rule 5550(b)(1), due to its failure to maintain a minimum of $2,500,000 in stockholders’ equity. In the Company’s Form 6-K dated November 13, 2024, the Company reported stockholders’ equity of approximately $2,158,000 as of September 30, 2024. In accordance with Nasdaq rules, the Company has … Continue reading "PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-29T18:08:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance\",\"datePublished\":\"2024-11-29T18:08:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/\"},\"wordCount\":862,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/\",\"name\":\"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg=\",\"datePublished\":\"2024-11-29T18:08:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/","og_locale":"en_US","og_type":"article","og_title":"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance - Market Newsdesk","og_description":"PETACH TIKVA, Israel, Nov. 29, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (\u201cPolyPid\u201d or the \u201cCompany\u201d), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it has received a written notification (the “Notification Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (\u201cNasdaq\u201d) notifying the Company that it is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, listing Rule 5550(b)(1), due to its failure to maintain a minimum of $2,500,000 in stockholders’ equity. In the Company’s Form 6-K dated November 13, 2024, the Company reported stockholders’ equity of approximately $2,158,000 as of September 30, 2024. In accordance with Nasdaq rules, the Company has … Continue reading \"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/","og_site_name":"Market Newsdesk","article_published_time":"2024-11-29T18:08:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance","datePublished":"2024-11-29T18:08:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/"},"wordCount":862,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/","name":"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg=","datePublished":"2024-11-29T18:08:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTI5MTI3MyM2NjEzNTQwIzIwMTY2MTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/polypid-announces-receipt-of-nasdaq-notification-of-minimum-stockholders-equity-non-compliance-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PolyPid Announces Receipt of Nasdaq Notification of Minimum Stockholders\u2019 Equity Non-Compliance"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/791298","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=791298"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/791298\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=791298"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=791298"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=791298"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}